term,TopCut_highestMinuslogP_down,maximum_MinuslogP_down,sum_MinuslogP_down,times_significant_down,FirstTopCut_significant_down,PEBBA_score_down
Fertilization,800,0.0675301427132985,0.6726114315457223,0.0,0,0.7558528567073262
Reproduction,800,0.0675301427132985,0.6726114315457223,0.0,0,0.7558528567073262
Miscellaneous transport and binding events,100,-0.0,0.0,0.0,0,0.5
Uptake and actions of bacterial toxins,100,-0.0,0.0,0.0,0,0.5
Dopamine Neurotransmitter Release Cycle,100,-0.0,0.0,0.0,0,0.5
Serotonin Neurotransmitter Release Cycle,100,-0.0,0.0,0.0,0,0.5
Norepinephrine Neurotransmitter Release Cycle,100,-0.0,0.0,0.0,0,0.5
Acetylcholine Neurotransmitter Release Cycle,100,-0.0,0.0,0.0,0,0.5
Glutamate Neurotransmitter Release Cycle,800,0.0675301427132985,0.6726114315457223,0.0,0,0.7558528567073262
Neurotransmitter Release Cycle,1150,0.10913982413415046,1.3678950274506434,0.0,0,0.7958161345719641
GABA synthesis release reuptake and degradation,800,0.0675301427132985,0.6798013788052186,0.0,0,0.7558528567073262
Na+slashCl_ dependent neurotransmitter transporters,100,-0.0,0.0,0.0,0,0.5
Amine compound SLC transporters,100,-0.0,0.0,0.0,0,0.5
Transport of inorganic cationsslashanions and amino acidsslasholigopeptides,100,-0.0,0.0,0.0,0,0.5
Amino acid transport across the plasma membrane,100,-0.0,0.0,0.0,0,0.5
Amino acid and oligopeptide SLC transporters,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Zinc transporters,1500,0.09124997924442099,0.2451207538666824,0.0,0,0.8126836397549246
Metal ion SLC transporters,1500,0.17568908709484918,1.0984692924790265,0.0,0,0.8278510921485196
Amino acid synthesis and interconversion transamination,100,-0.0,0.0,0.0,0,0.5
Transport of vitamins nucleosides and related molecules,900,0.1841207636289789,1.8297380049924994,0.0,0,0.7920411644234762
Disorders of transmembrane transporters,100,-0.0,0.0,0.0,0,0.5
Surfactant metabolism,1500,0.13002790000111852,1.4125441193645534,0.0,0,0.8198083453163852
ABC transporters in lipid homeostasis,100,-0.0,0.0,0.0,0,0.5
ABC_family proteins mediated transport,1200,0.05608238587204735,0.45420808864640305,0.0,0,0.7882079483077002
Signaling by Retinoic Acid,100,-0.0,0.0,0.0,0,0.5
RA biosynthesis pathway,100,-0.0,0.0,0.0,0,0.5
The canonical retinoid cycle in rods twilight vision,100,-0.0,0.0,0.0,0,0.5
Visual phototransduction,100,-0.0,0.0,0.0,0,0.5
Retinoid metabolism and transport,100,-0.0,0.0,0.0,0,0.5
Metabolism of fat_soluble vitamins,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
HS_GAG degradation,100,-0.0,0.0,0.0,0,0.5
Diseases associated with glycosaminoglycan metabolism,100,-0.0,0.0,0.0,0,0.5
Defective B3GALT6 causes EDSP2 and SEMDJL1,100,-0.0,0.0,0.0,0,0.5
Defective B4GALT7 causes EDS progeroid type,100,-0.0,0.0,0.0,0,0.5
Defective B3GAT3 causes JDSSDHD,100,-0.0,0.0,0.0,0,0.5
A tetrasaccharide linker sequence is required for GAG synthesis,100,-0.0,0.0,0.0,0,0.5
Heparan sulfateslashheparin HS_GAG metabolism,100,-0.0,0.0,0.0,0,0.5
HS_GAG biosynthesis,100,-0.0,0.0,0.0,0,0.5
Chondroitin sulfateslashdermatan sulfate metabolism,800,0.10021721845327296,0.747965646953138,0.0,0,0.7637042935597635
Chondroitin sulfate biosynthesis,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Keratan sulfate biosynthesis,1150,0.001997248549708538,0.004154695875152062,0.0,0,0.7727243803087316
Keratan sulfateslashkeratin metabolism,100,-0.0,0.0,0.0,0,0.5
Diseases of glycosylation,150,0.2239817111176492,1.423675620034334,0.0,0,0.640709474887557
Diseases associated with O_glycosylation of proteins,150,0.3150697373977847,3.5902526515876185,0.0,0,0.6719902619619795
Defective B3GALTL causes Peters_plus syndrome PpS,200,0.11033075205268685,1.4555185039210605,0.0,0,0.6290560622845343
O_glycosylation of TSR domain_containing proteins,800,0.08134033122299195,1.1465071233108657,0.0,0,0.7592013995566073
O_linked glycosylation of mucins,1450,0.06372083653729702,0.29737667516568433,0.0,0,0.8048483710090721
Termination of O_glycan biosynthesis,1500,0.09124997924442099,0.7188287688233227,0.0,0,0.8126836397549246
Defective GALNT12 causes colorectal cancer 1 CRCS1,100,-0.0,0.0,0.0,0,0.5
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis HFTC,100,-0.0,0.0,0.0,0,0.5
Defective C1GALT1C1 causes Tn polyagglutination syndrome TNPS,1450,0.06882285006695776,0.3181439351651155,0.0,0,0.8058415016232943
Elastic fibre formation,800,0.02764054316806752,0.16788547628333778,0.0,0,0.7459170751916115
Molecules associated with elastic fibres,800,0.047169876639660914,0.4717496668259154,0.0,0,0.7508310062821557
ECM proteoglycans,800,0.01520921727177638,0.026313377149554035,0.0,0,0.7427387732254271
Integrin cell surface interactions,1400,0.3639061699324992,5.756241581802893,0.0,0,0.853435973373336
Syndecan interactions,100,-0.0,0.0,0.0,0,0.5
Non_integrin membrane_ECM interactions,100,-0.0,0.0,0.0,0,0.5
Laminin interactions,1500,0.13002790000111852,0.45386238580601357,0.0,0,0.8198083453163852
Assembly of collagen fibrils and other multimeric structures,1500,0.13002790000111852,0.5073629090501386,0.0,0,0.8198083453163852
Collagen formation,1400,0.43218163553152056,5.64407144732868,0.0,0,0.8631087371023446
Collagen biosynthesis and modifying enzymes,1500,0.31483894963528014,4.033879785500708,0.0,0,0.8502136443650359
Collagen degradation,150,0.2945894421007127,2.4937846318898016,0.0,0,0.6652032630234135
Activation of Matrix Metalloproteinases,1500,0.17568908709484918,2.2268584678337593,0.0,0,0.8278510921485196
Hyaluronan metabolism,1450,0.10896379234604296,0.6290995432342648,0.0,0,0.813480855523966
Activation of SMO,200,0.11033075205268685,1.4555185039210605,0.0,0,0.6290560622845343
Synthesis of glycosylphosphatidylinositol GPI,1150,0.10913982413415046,1.501425276888579,0.0,0,0.7958161345719641
Post_translational modification: synthesis of GPI_anchored proteins,950,0.12564231685883143,1.3941105829338554,0.0,0,0.7839574912215851
Common Pathway of Fibrin Clot Formation,1450,0.025201670625174952,0.06513446338131886,0.0,0,0.7971846403268208
Formation of Fibrin Clot Clotting Cascade,1500,0.13002790000111852,0.37920435371951605,0.0,0,0.8198083453163852
Intrinsic Pathway of Fibrin Clot Formation,1500,0.31292422231516237,0.9194936413732139,0.0,0,0.8499265695904695
Gamma carboxylation hypusine formation and arylsulfatase activation,1450,0.07001558933766029,0.6667179895038535,0.0,0,0.8060729440363833
Glycosphingolipid metabolism,1500,0.28977693676947824,2.3517345887132843,0.0,0,0.8464122605986615
Sphingolipid metabolism,800,0.1948832143492539,2.0283019118705363,0.0,0,0.7850472969357967
Sphingolipid de novo biosynthesis,800,0.047169876639660914,0.19710574072431516,0.0,0,0.7508310062821557
TNF receptor superfamily TNFSF members mediating non_canonical NF_kB pathway,550,0.2996929911535368,4.779204888554676,0.0,0,0.778475443097151
TNFs bind their physiological receptors,100,-0.0,0.0,0.0,0,0.5
Beta defensins,100,-0.0,0.0,0.0,0,0.5
Defensins,800,0.01520921727177638,0.06366776937313827,0.0,0,0.7427387732254271
Depolymerisation of the Nuclear Lamina,100,-0.0,0.0,0.0,0,0.5
Gap junction assembly,150,0.6777895529864434,6.4528454826609485,0.0,0,0.7717769405788981
Gap junction trafficking,150,0.3150697373977847,2.8823846418679535,0.0,0,0.6719902619619795
Gap junction trafficking and regulation,150,0.9301918493443451,7.402946722633746,0.06896551724137931,150,0.8226861750153173
Golgi Associated Vesicle Biogenesis,400,0.302511616830827,3.157063922194131,0.0,0,0.7536800320543695
trans_Golgi Network Vesicle Budding,250,0.4066545664389463,4.188199185234841,0.0,0,0.7420231108447566
Clathrin derived vesicle budding,250,0.4066545664389463,4.188199185234841,0.0,0,0.7420231108447566
Lysosome Vesicle Biogenesis,400,0.37656257840767643,3.9438167917509266,0.0,0,0.7712612753241275
Nef_mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,250,0.22254884832195634,1.843873870004866,0.0,0,0.6898749131349897
The role of Nef in HIV_1 replication and disease pathogenesis,950,0.1706012552461307,1.6407545534865853,0.0,0,0.7934554247596965
Trafficking of GluR2_containing AMPA receptors,1500,0.17568908709484918,0.9472425236702189,0.0,0,0.8278510921485196
Trafficking of AMPA receptors,1500,0.26042306652797376,1.0645554302896552,0.0,0,0.8418370443888685
Glutamate Binding Activation of AMPA Receptors and Synaptic Plasticity,1500,0.26042306652797376,1.0645554302896552,0.0,0,0.8418370443888685
EGFR downregulation,100,-0.0,0.0,0.0,0,0.5
WNT5A_dependent internalization of FZD4,1200,0.0017457216928118953,0.0017457216928118953,0.0,0,0.776381478905428
Recycling pathway of L1,1200,0.07604818788844754,0.394192123053563,0.0,0,0.792394612350046
L1CAM interactions,950,0.12564231685883143,1.1988949340982904,0.0,0,0.7839574912215851
Interaction between L1 and Ankyrins,100,-0.0,0.0,0.0,0,0.5
Biosynthesis of the N_glycan precursor dolichol lipid_linked oligosaccharide LLO and transfer to a nascent protein,1500,0.10104582710258099,0.7413421799573096,0.0,0,0.8145096042844681
Synthesis of substrates in N_glycan biosythesis,1450,0.10896379234604296,0.735656387491997,0.0,0,0.813480855523966
Sialic acid metabolism,1200,0.07604818788844754,0.5761797451689802,0.0,0,0.792394612350046
N_Glycan antennae elongation,950,0.01756249537188803,0.12332883721953954,0.0,0,0.7592991178522379
N_glycan antennae elongation in the medialslashtrans_Golgi,100,-0.0,0.0,0.0,0,0.5
Intra_Golgi traffic,1200,0.06841073516763335,0.528418357764842,0.0,0,0.7908029656910424
Retrograde transport at the Trans_Golgi_Network,950,0.12564231685883143,1.177574277029314,0.0,0,0.7839574912215851
COPI_dependent Golgi_to_ER retrograde traffic,800,0.09950718856131845,0.3821584011895818,0.0,0,0.7635364569674028
Kinesins,800,0.0675301427132985,0.5494312676760219,0.0,0,0.7558528567073262
COPI_independent Golgi_to_ER retrograde traffic,100,-0.0,0.0,0.0,0,0.5
COPI_mediated anterograde transport,1100,0.0059647812655248015,0.013533954533436246,0.0,0,0.7697152240458434
COPII Coat Protein 2 Mediated Vesicle Transport,1500,0.26042306652797376,3.212550754141048,0.0,0,0.8418370443888685
Cargo concentration in the ER,250,0.6424830606659405,6.238171809449357,0.0,0,0.7962198921558111
Intraflagellar transport,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Antigen Presentation: Folding assembly and peptide loading of class I MHC,300,0.19758557634832308,3.22638345631944,0.0,0,0.6995993259012072
N_glycan trimming in the ER and CalnexinslashCalreticulin cycle,1200,0.05608238587204735,0.31147191690958714,0.0,0,0.7882079483077002
Calnexinslashcalreticulin cycle,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
XBP1S activates chaperone genes,100,-0.0,0.0,0.0,0,0.5
IRE1alpha activates chaperones,1200,0.01504961556740963,0.0206544547969887,0.0,0,0.7793367739239226
Unfolded Protein Response UPR,1200,0.04371792894085783,0.1364267116695832,0.0,0,0.7855729983124489
PERK regulates gene expression,1200,0.10836769743018664,0.81648158416858,0.0,0,0.798997048207853
ATF4 activates genes,1200,0.07604818788844754,0.6922625749380165,0.0,0,0.792394612350046
KSRP KHSRP binds and destabilizes mRNA,1500,0.13002790000111852,0.6981053627671281,0.0,0,0.8198083453163852
Tristetraprolin TTP ZFP36 binds and destabilizes mRNA,1450,0.06882285006695776,0.4413328035807351,0.0,0,0.8058415016232943
Butyrate Response Factor 1 BRF1 binds and destabilizes mRNA,1450,0.10896379234604296,0.6376306742925513,0.0,0,0.813480855523966
mRNA decay by 5  to 3  exoribonuclease,1450,0.06882285006695776,0.522281696471087,0.0,0,0.8058415016232943
Deadenylation_dependent mRNA decay,1200,0.06841073516763335,0.429976063592523,0.0,0,0.7908029656910424
Deadenylation of mRNA,100,-0.0,0.0,0.0,0,0.5
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,950,0.056514478390006714,0.5107225670364097,0.0,0,0.7684946399804349
TP53 Regulates Transcription of Cell Cycle Genes,1450,0.05856935004052834,0.24864023341531274,0.0,0,0.8038404561265364
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,100,-0.0,0.0,0.0,0,0.5
TP53 Regulates Transcription of Cell Death Genes,800,0.08134033122299195,0.5258148396418413,0.0,0,0.7592013995566073
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,800,0.1101896041443778,1.086157848303314,0.0,0,0.7660490148176294
Intrinsic Pathway for Apoptosis,1450,0.041204960094945106,0.14244166417603285,0.0,0,0.8004045201831624
Activation of BH3_only proteins,1450,0.06372083653729702,0.32548941870049475,0.0,0,0.8048483710090721
Activation of BAD and translocation to mitochondria,450,0.1338235900256267,2.095586441095798,0.0,0,0.719751813866607
Translocation of GLUT4 to the plasma membrane,800,0.10021721845327296,0.640073980389241,0.0,0,0.7637042935597635
TP53 Regulates Metabolic Genes,1350,0.1031389028070214,0.8323293001520126,0.0,0,0.8070268720616478
PI3K Cascade,1500,0.13002790000111852,0.5960149580941111,0.0,0,0.8198083453163852
mTORC1_mediated signalling,1000,0.017316427043655668,0.08849574898376902,0.0,0,0.7638714375053248
PKB_mediated events,1450,0.03910415857997151,0.1544804655194879,0.0,0,0.7999847689441382
mTOR signalling,1450,0.041204960094945106,0.17225337062069745,0.0,0,0.8004045201831624
Energy dependent regulation of mTOR by LKB1_AMPK,800,0.02764054316806752,0.0621252725479506,0.0,0,0.7459170751916115
Macroautophagy,100,-0.0,0.0,0.0,0,0.5
PD_1 signaling,1500,0.28977693676947824,3.446901240899976,0.0,0,0.8464122605986615
Phosphorylation of CD3 and TCR zeta chains,1500,0.28977693676947824,3.468707457789716,0.0,0,0.8464122605986615
Translocation of ZAP_70 to Immunological synapse,1500,0.13002790000111852,1.7474054098748066,0.0,0,0.8198083453163852
Generation of second messenger molecules,800,0.1101896041443778,1.680672277064547,0.0,0,0.7660490148176294
Costimulation by the CD28 family,1450,0.6795219338345941,6.587478836624651,0.0,0,0.8945775360690333
CD28 co_stimulation,1500,0.17568908709484918,1.4986488177559443,0.0,0,0.8278510921485196
CD28 dependent PI3KslashAkt signaling,1500,0.1043497372243159,0.28320174807546356,0.0,0,0.8151214366043058
VEGFR2 mediated vascular permeability,1500,0.13002790000111852,0.6722782766831188,0.0,0,0.8198083453163852
Constitutive Signaling by AKT1 E17K in Cancer,1350,0.10739780895182353,0.9812010956311394,0.0,0,0.8078469788834046
Regulation of TP53 Activity through Acetylation,1500,0.13002790000111852,0.9139530119364544,0.0,0,0.8198083453163852
Regulation of gene expression in beta cells,1500,0.1043497372243159,0.3993944281640664,0.0,0,0.8151214366043058
Regulation of beta_cell development,1500,0.13002790000111852,1.3274449432890032,0.0,0,0.8198083453163852
Regulation of innate immune responses to cytosolic DNA,100,-0.0,0.0,0.0,0,0.5
STING mediated induction of host immune responses,100,-0.0,0.0,0.0,0,0.5
HSF1 activation,100,-0.0,0.0,0.0,0,0.5
Attenuation phase,100,-0.0,0.0,0.0,0,0.5
HSF1_dependent transactivation,100,-0.0,0.0,0.0,0,0.5
Cellular response to heat stress,1500,0.20215607490396495,1.6533516204487804,0.0,0,0.83234758835835
Regulation of HSF1_mediated heat shock response,1500,0.21840284938188684,1.7444924343201564,0.0,0,0.8350493920534212
SUMOylation of DNA damage response and repair proteins,1500,0.06957634167270539,0.48754534782702574,0.0,0,0.8085794976652525
SUMO E3 ligases SUMOylate target proteins,1500,0.06297879021735711,0.15698332280065197,0.0,0,0.8073124158287749
Transcriptional regulation by small RNAs,1500,0.31483894963528014,2.657642626246807,0.0,0,0.8502136443650359
Nuclear Envelope Breakdown,1500,0.13002790000111852,0.9093753735034021,0.0,0,0.8198083453163852
Metabolism of non_coding RNA,1500,0.17568908709484918,1.8917778825533338,0.0,0,0.8278510921485196
snRNP Assembly,1500,0.17568908709484918,1.8917778825533338,0.0,0,0.8278510921485196
SUMOylation of RNA binding proteins,1500,0.19270289616245093,1.7261486916389435,0.0,0,0.8307552255576883
Hexose transport,1500,0.7763307325493324,5.6864566543347035,0.034482758620689655,1500,0.9055832777311599
Glucose transport,1500,0.5885337244628577,3.8878839969431715,0.0,0,0.8860778627764168
SUMOylation of DNA replication proteins,1500,0.28977693676947824,1.690828231560595,0.0,0,0.8464122605986615
Viral Messenger RNA Synthesis,1500,0.785284612066126,5.985620556551212,0.034482758620689655,1500,0.9064249001708946
Transport of Mature mRNA Derived from an Intronless Transcript,1500,0.28977693676947824,1.7305018222775277,0.0,0,0.8464122605986615
Transport of Mature mRNAs Derived from Intronless Transcripts,1500,0.28977693676947824,1.7156075728768583,0.0,0,0.8464122605986615
Transport of the SLBP Dependant Mature mRNA,1500,0.26042306652797376,1.920766162786705,0.0,0,0.8418370443888685
Transport of the SLBP independent Mature mRNA,1500,0.28977693676947824,2.033928731459654,0.0,0,0.8464122605986615
Nuclear Pore Complex NPC Disassembly,1500,0.31483894963528014,2.1779516820615354,0.0,0,0.8502136443650359
Nuclear import of Rev protein,1500,0.31483894963528014,2.1779516820615354,0.0,0,0.8502136443650359
Interactions of Rev with host cellular proteins,1500,0.28977693676947824,2.033928731459654,0.0,0,0.8464122605986615
Rev_mediated nuclear export of HIV RNA,1500,0.28977693676947824,2.094994241982311,0.0,0,0.8464122605986615
NEPslashNS2 Interacts with the Cellular Export Machinery,1500,0.31483894963528014,2.1779516820615354,0.0,0,0.8502136443650359
Export of Viral Ribonucleoproteins from Nucleus,1500,0.31292422231516237,2.1548097616013493,0.0,0,0.8499265695904695
Regulation of Glucokinase by Glucokinase Regulatory Protein,1500,0.31483894963528014,2.2177854800556154,0.0,0,0.8502136443650359
Transport of Ribonucleoproteins into the Host Nucleus,1500,0.31483894963528014,2.1779516820615354,0.0,0,0.8502136443650359
Vpr_mediated nuclear import of PICs,1500,0.32921058525790037,2.1833120928532512,0.0,0,0.8523509243978131
Interactions of Vpr with host cellular proteins,1500,0.31483894963528014,1.9969011283755584,0.0,0,0.8502136443650359
Host Interactions with Influenza Factors,1500,0.28977693676947824,1.950847307011696,0.0,0,0.8464122605986615
NS1 Mediated Effects on Host Pathways,1500,0.28977693676947824,1.9669591621313485,0.0,0,0.8464122605986615
ISG15 antiviral mechanism,1500,0.17568908709484918,1.3239482887233183,0.0,0,0.8278510921485196
Antiviral mechanism by IFN_stimulated genes,1500,0.17568908709484918,1.3239482887233183,0.0,0,0.8278510921485196
tRNA processing in the nucleus,1500,0.26042306652797376,1.977800731463096,0.0,0,0.8418370443888685
Cleavage of Growing Transcript in the Termination Region,1150,0.024446035924954194,0.06487897330972711,0.0,0,0.7777696009523652
RNA Polymerase II Transcription Termination,1150,0.024446035924954194,0.06487897330972711,0.0,0,0.7777696009523652
Post_Elongation Processing of the Transcript,1150,0.024446035924954194,0.06487897330972711,0.0,0,0.7777696009523652
mRNA 3 _end processing,1200,0.05154534951878434,0.25289239060834956,0.0,0,0.787244856931626
Post_Elongation Processing of Intron_Containing pre_mRNA,1200,0.05154534951878434,0.25289239060834956,0.0,0,0.787244856931626
Transport of Mature Transcript to Cytoplasm,1500,0.26042306652797376,1.5814674933407238,0.0,0,0.8418370443888685
Transport of Mature mRNA derived from an Intron_Containing Transcript,1500,0.26042306652797376,1.8253911183175253,0.0,0,0.8418370443888685
mRNA Splicing _ Minor Pathway,800,0.1101896041443778,1.3005106583780313,0.0,0,0.7660490148176294
Post_Elongation Processing of Intronless pre_mRNA,100,-0.0,0.0,0.0,0,0.5
Processing of Capped Intronless Pre_mRNA,100,-0.0,0.0,0.0,0,0.5
Processing of Intronless Pre_mRNAs,100,-0.0,0.0,0.0,0,0.5
rRNA modification in the nucleus,1450,0.041204960094945106,0.12138806753022502,0.0,0,0.8004045201831624
Selenocysteine synthesis,100,-0.0,0.0,0.0,0,0.5
Viral mRNA Translation,100,-0.0,0.0,0.0,0,0.5
Peptide chain elongation,100,-0.0,0.0,0.0,0,0.5
Eukaryotic Translation Elongation,100,-0.0,0.0,0.0,0,0.5
Eukaryotic Translation Termination,100,-0.0,0.0,0.0,0,0.5
Nonsense Mediated Decay NMD independent of the Exon Junction Complex EJC,100,-0.0,0.0,0.0,0,0.5
Formation of a pool of free 40S subunits,100,-0.0,0.0,0.0,0,0.5
Formation of the ternary complex and subsequently the 43S complex,100,-0.0,0.0,0.0,0,0.5
Ribosomal scanning and start codon recognition,100,-0.0,0.0,0.0,0,0.5
Translation initiation complex formation,100,-0.0,0.0,0.0,0,0.5
Activation of the mRNA upon binding of the cap_binding complex and eIFs and subsequent binding to 43S,100,-0.0,0.0,0.0,0,0.5
Formation of Senescence_Associated Heterochromatin Foci SAHF,1000,0.13751176623362918,1.203849631633389,0.0,0,0.7906136575844264
DNA DamageslashTelomere Stress Induced Senescence,1200,0.0750889538528962,0.4961880972567375,0.0,0,0.7921953746537357
Oxidative Stress Induced Senescence,100,-0.0,0.0,0.0,0,0.5
Senescence_Associated Secretory Phenotype SASP,150,0.4065370697194881,3.5701853351517134,0.0,0,0.7006612232022076
Amyloid fiber formation,100,-0.0,0.0,0.0,0,0.5
Deposition of new CENPA_containing nucleosomes at the centromere,1250,0.014266107910941673,0.03366070928826688,0.0,0,0.7826418694550563
Nucleosome assembly,1250,0.014266107910941673,0.03366070928826688,0.0,0,0.7826418694550563
Chromosome Maintenance,100,-0.0,0.0,0.0,0,0.5
Telomere Maintenance,100,-0.0,0.0,0.0,0,0.5
Meiotic recombination,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Meiosis,100,-0.0,0.0,0.0,0,0.5
Meiotic synapsis,100,-0.0,0.0,0.0,0,0.5
Packaging Of Telomere Ends,100,-0.0,0.0,0.0,0,0.5
SIRT1 negatively regulates rRNA Expression,100,-0.0,0.0,0.0,0,0.5
Activated PKN1 stimulates transcription of AR androgen receptor regulated genes KLK2 and KLK3,100,-0.0,0.0,0.0,0,0.5
RNA Polymerase I Promoter Opening,100,-0.0,0.0,0.0,0,0.5
DNA methylation,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
PRC2 methylates histones and DNA,100,-0.0,0.0,0.0,0,0.5
Condensation of Prophase Chromosomes,950,0.034254516651492796,0.2288363674300064,0.0,0,0.7632835554279108
ERCC6 CSB and EHMT2 G9a positively regulate rRNA expression,100,-0.0,0.0,0.0,0,0.5
RHO GTPases activate PKNs,100,-0.0,0.0,0.0,0,0.5
Formation of the beta_catenin:TCF transactivating complex,1200,0.05608238587204735,0.5037107679550726,0.0,0,0.7882079483077002
Activation of anterior HOX genes in hindbrain development during early embryogenesis,950,0.12564231685883143,1.095647442074627,0.0,0,0.7839574912215851
Activation of HOX genes during differentiation,950,0.12564231685883143,1.095647442074627,0.0,0,0.7839574912215851
B_WICH complex positively regulates rRNA expression,800,0.04120550659876314,0.25113777642430885,0.0,0,0.7493404294437616
Positive epigenetic regulation of rRNA expression,800,0.0525761294360238,0.2271111335453716,0.0,0,0.7521744421022681
Negative epigenetic regulation of rRNA expression,800,0.10531717060413566,0.9002044417968403,0.0,0,0.7649063226054068
NoRC negatively regulates rRNA expression,800,0.1101896041443778,0.8731425329369956,0.0,0,0.7660490148176294
RNA Polymerase I Chain Elongation,1450,0.06882285006695776,0.3966943932978983,0.0,0,0.8058415016232943
RNA Polymerase I Transcription,1450,0.05264385469384382,0.19379520023769328,0.0,0,0.802674663122656
RNA Polymerase I Promoter Clearance,1450,0.05856935004052834,0.24671104722586923,0.0,0,0.8038404561265364
RNA Polymerase I Transcription Initiation,800,0.1101896041443778,1.2186781162048312,0.0,0,0.7660490148176294
RNA Polymerase I Promoter Escape,1500,0.15999045353100752,1.5598077110404533,0.0,0,0.8251272652855423
RNA Polymerase I Transcription Termination,1500,0.15999045353100752,1.5598077110404533,0.0,0,0.8251272652855423
RMTs methylate histone arginines,950,0.034254516651492796,0.16312251379971265,0.0,0,0.7632835554279108
HDACs deacetylate histones,950,0.034254516651492796,0.15312457976650734,0.0,0,0.7632835554279108
PKMTs methylate histone lysines,100,-0.0,0.0,0.0,0,0.5
HDMs demethylate histones,1450,0.10896379234604296,0.6653548351169223,0.0,0,0.813480855523966
Transcriptional regulation of pluripotent stem cells,750,0.25314381213739,2.3060061365559967,0.0,0,0.7923410985653682
RNA Polymerase III Transcription Termination,750,0.20762448832289396,2.3528238230468808,0.0,0,0.7826701684857847
RNA Polymerase III Chain Elongation,750,0.25314381213739,2.831230768963119,0.0,0,0.7923410985653682
RNA Polymerase III Transcription Initiation From Type 2 Promoter,450,0.2867462026545792,3.3723121469462765,0.0,0,0.7594920904405257
RNA Polymerase III Transcription Initiation From Type 1 Promoter,750,0.25314381213739,3.247017381728395,0.0,0,0.7923410985653682
RNA Polymerase III Abortive And Retractive Initiation,750,0.25314381213739,2.97577122243368,0.0,0,0.7923410985653682
RNA Polymerase III Transcription,750,0.25314381213739,2.97577122243368,0.0,0,0.7923410985653682
RNA Polymerase III Transcription Initiation,1500,0.28977693676947824,3.408566395894165,0.0,0,0.8464122605986615
RNA Polymerase III Transcription Initiation From Type 3 Promoter,750,0.25314381213739,2.6508318350919042,0.0,0,0.7923410985653682
RNA polymerase II transcribes snRNA genes,1450,0.11535990978070296,1.0608122370436501,0.0,0,0.8146700467184014
PIWI_interacting RNA piRNA biogenesis,750,0.25314381213739,2.3060061365559967,0.0,0,0.7923410985653682
MicroRNA miRNA biogenesis,1500,0.28977693676947824,3.6789522041351357,0.0,0,0.8464122605986615
FGFR2 alternative splicing,750,0.7519852775764003,5.02746342388685,0.034482758620689655,750,0.8739025058040766
Signaling by FGFR2 IIIa TM,750,0.25314381213739,2.399148640664987,0.0,0,0.7923410985653682
Abortive elongation of HIV_1 transcript in the absence of Tat,750,0.25314381213739,2.244669452899712,0.0,0,0.7923410985653682
Formation of the Early Elongation Complex,900,0.1841207636289789,1.908559775830742,0.0,0,0.7920411644234762
Formation of the HIV_1 Early Elongation Complex,900,0.1841207636289789,1.908559775830742,0.0,0,0.7920411644234762
Formation of HIV elongation complex in the absence of HIV Tat,950,0.16005018463530285,1.2213890089077775,0.0,0,0.7912646210238446
RNA Polymerase II Transcription Elongation,950,0.16005018463530285,1.2213890089077775,0.0,0,0.7912646210238446
Formation of RNA Pol II elongation complex,950,0.16005018463530285,1.2213890089077775,0.0,0,0.7912646210238446
HIV Transcription Elongation,950,0.1627093614634903,1.2873066161497122,0.0,0,0.7918189479535302
Tat_mediated elongation of the HIV_1 transcript,950,0.1627093614634903,1.2873066161497122,0.0,0,0.7918189479535302
Formation of HIV_1 elongation complex containing HIV_1 Tat,950,0.1627093614634903,1.2873066161497122,0.0,0,0.7918189479535302
Pausing and recovery of Tat_mediated HIV elongation,900,0.1841207636289789,1.8393866755933521,0.0,0,0.7920411644234762
Tat_mediated HIV elongation arrest and recovery,900,0.1841207636289789,1.8393866755933521,0.0,0,0.7920411644234762
HIV elongation arrest and recovery,900,0.1841207636289789,1.8144482203262495,0.0,0,0.7920411644234762
Pausing and recovery of HIV elongation,900,0.1841207636289789,1.8144482203262495,0.0,0,0.7920411644234762
Elongation arrest and recovery,900,0.1841207636289789,1.8144482203262495,0.0,0,0.7920411644234762
TP53 Regulates Transcription of DNA Repair Genes,950,0.1706012552461307,1.379212637055203,0.0,0,0.7934554247596965
Transcription of the HIV genome,950,0.1627093614634903,1.3208360072679857,0.0,0,0.7918189479535302
RNA Polymerase II Pre_transcription Events,950,0.11947040097797544,1.0430111502708428,0.0,0,0.7826199717476654
RNA Polymerase II HIV Promoter Escape,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
RNA Polymerase II Promoter Escape,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
RNA Polymerase II Transcription Initiation And Promoter Clearance,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
RNA Polymerase II Transcription Initiation,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
RNA Polymerase II Transcription Pre_Initiation And Promoter Opening,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
HIV Transcription Initiation,750,0.25314381213739,2.0184256332429693,0.0,0,0.7923410985653682
RNA Pol II CTD phosphorylation and interaction with CE,750,0.25314381213739,2.244669452899712,0.0,0,0.7923410985653682
mRNA Capping,750,0.25314381213739,2.234432557443742,0.0,0,0.7923410985653682
Formation of TC_NER Pre_Incision Complex,1450,0.06882285006695776,0.6142869934537124,0.0,0,0.8058415016232943
Dual incision in TC_NER,800,0.1101896041443778,0.9468509692158608,0.0,0,0.7660490148176294
Gap_filling DNA repair synthesis and ligation in TC_NER,800,0.1101896041443778,0.9468509692158608,0.0,0,0.7660490148176294
Transcription_Coupled Nucleotide Excision Repair TC_NER,800,0.047169876639660914,0.3235946736883024,0.0,0,0.7508310062821557
Global Genome Nucleotide Excision Repair GG_NER,100,-0.0,0.0,0.0,0,0.5
Formation of Incision Complex in GG_NER,100,-0.0,0.0,0.0,0,0.5
DNA Damage Recognition in GG_NER,100,-0.0,0.0,0.0,0,0.5
Processing of DNA double_strand break ends,1450,0.041204960094945106,0.23898509531453346,0.0,0,0.8004045201831624
G2slashM DNA damage checkpoint,800,0.035759141494791716,0.10982918697416233,0.0,0,0.7479715215033013
Nonhomologous End_Joining NHEJ,100,-0.0,0.0,0.0,0,0.5
Recruitment and ATM_mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,100,-0.0,0.0,0.0,0,0.5
DNA Double Strand Break Response,100,-0.0,0.0,0.0,0,0.5
HDR through Single Strand Annealing SSA,750,0.25314381213739,2.479494692384795,0.0,0,0.7923410985653682
Presynaptic phase of homologous DNA pairing and strand exchange,750,0.25314381213739,2.479494692384795,0.0,0,0.7923410985653682
Homologous DNA Pairing and Strand Exchange,750,0.25314381213739,2.479494692384795,0.0,0,0.7923410985653682
HDR through Homologous Recombination HRR,800,0.1101896041443778,0.9002491052915964,0.0,0,0.7660490148176294
Resolution of D_loop Structures through Holliday Junction Intermediates,800,0.0970227383074923,0.8904572913291098,0.0,0,0.7629482446683584
Resolution of D_Loop Structures,800,0.08134033122299195,0.7161899621280864,0.0,0,0.7592013995566073
Resolution of D_loop Structures through Synthesis_Dependent Strand Annealing SDSA,800,0.1101896041443778,1.3203051273762405,0.0,0,0.7660490148176294
Regulation of TP53 Activity through Phosphorylation,950,0.1627093614634903,1.4972224477157636,0.0,0,0.7918189479535302
Regulation of TP53 Expression and Degradation,1450,0.06882285006695776,0.2255129371426866,0.0,0,0.8058415016232943
Regulation of TP53 Degradation,1450,0.06882285006695776,0.23261534128154407,0.0,0,0.8058415016232943
Regulation of TP53 Activity through Methylation,100,-0.0,0.0,0.0,0,0.5
Translesion Synthesis by POLH,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Translesion synthesis by POLK,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Translesion synthesis by REV1,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Translesion synthesis by POLI,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Termination of translesion DNA synthesis,100,-0.0,0.0,0.0,0,0.5
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,100,-0.0,0.0,0.0,0,0.5
DNA Damage Bypass,100,-0.0,0.0,0.0,0,0.5
Recognition of DNA damage by PCNA_containing replication complex,100,-0.0,0.0,0.0,0,0.5
Gap_filling DNA repair synthesis and ligation in GG_NER,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Dual Incision in GG_NER,100,-0.0,0.0,0.0,0,0.5
Base Excision Repair,1450,0.07001558933766029,0.41336761458541676,0.0,0,0.8060729440363833
Resolution of Abasic Sites AP sites,1450,0.07001558933766029,0.41336761458541676,0.0,0,0.8060729440363833
Resolution of AP sites via the multiple_nucleotide patch replacement pathway,1200,0.05608238587204735,0.4079267385886555,0.0,0,0.7882079483077002
PCNA_Dependent Long Patch Base Excision Repair,1200,0.06841073516763335,0.46611639416672546,0.0,0,0.7908029656910424
Extension of Telomeres,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Telomere C_strand Lagging Strand Synthesis,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Lagging Strand Synthesis,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
DNA strand elongation,800,0.035759141494791716,0.17476679349196148,0.0,0,0.7479715215033013
Mismatch Repair,100,-0.0,0.0,0.0,0,0.5
Processive synthesis on the lagging strand,100,-0.0,0.0,0.0,0,0.5
E2F mediated regulation of DNA replication,550,0.19408759122189692,2.00015892825057,0.0,0,0.7538013206379259
G1slashS_Specific Transcription,100,-0.0,0.0,0.0,0,0.5
Association of licensing factors with the pre_replicative complex,950,0.12735392784893831,1.6457854194472517,0.0,0,0.7843269556740329
Activation of ATR in response to replication stress,550,0.2996929911535368,3.0084804873024344,0.0,0,0.778475443097151
Activation of the pre_replicative complex,550,0.19408759122189692,2.00015892825057,0.0,0,0.7538013206379259
G0 and Early G1,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Signal transduction by L1,950,0.1627093614634903,1.4792458452977393,0.0,0,0.7918189479535302
RAF_independent MAPK1slash3 activation,1500,0.31292422231516237,1.7739094356178717,0.0,0,0.8499265695904695
Interleukin_6 family signaling,200,0.6706499751798503,6.046832478870924,0.0,0,0.7881810888860366
IL_6_type cytokine receptor ligand interactions,200,1.1290211730268376,8.63494458734815,0.06896551724137931,200,0.8660642082678998
Regulation of IFNA signaling,1500,0.1043497372243159,0.47707301263946295,0.0,0,0.8151214366043058
Interferon alphaslashbeta signaling,100,-0.0,0.0,0.0,0,0.5
Interferon gamma signaling,1500,0.13002790000111852,0.5347913154992359,0.0,0,0.8198083453163852
Growth hormone receptor signaling,1500,0.019604152474939174,0.019604152474939174,0.0,0,0.7987707550662555
Prolactin receptor signaling,100,-0.0,0.0,0.0,0,0.5
Nuclear signaling by ERBB4,100,-0.0,0.0,0.0,0,0.5
NOTCH1 Intracellular Domain Regulates Transcription,450,0.17630305411643743,1.6207665568779612,0.0,0,0.7314072946914469
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,450,0.3011260645497226,2.4951384048426113,0.0,0,0.76292581356384
Signaling by NOTCH1 in Cancer,450,0.3011260645497226,2.4951384048426113,0.0,0,0.76292581356384
Signaling by NOTCH1 PEST Domain Mutants in Cancer,450,0.3011260645497226,2.4951384048426113,0.0,0,0.76292581356384
Constitutive Signaling by NOTCH1 PEST Domain Mutants,450,0.3011260645497226,2.4951384048426113,0.0,0,0.76292581356384
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,450,0.3011260645497226,2.4951384048426113,0.0,0,0.76292581356384
Signaling by NOTCH1,450,0.32873632902377,3.1381193906860734,0.0,0,0.7693819565085819
Constitutive Signaling by NOTCH1 HD Domain Mutants,800,0.01520921727177638,0.026313377149554035,0.0,0,0.7427387732254271
Signaling by NOTCH1 HD Domain Mutants in Cancer,800,0.01520921727177638,0.026313377149554035,0.0,0,0.7427387732254271
Activated NOTCH1 Transmits Signal to the Nucleus,150,0.17879837200098012,0.6733170900174519,0.0,0,0.6241031906593362
NOTCH2 Activation and Transmission of Signal to the Nucleus,800,0.0012036413005548805,0.0012036413005548805,0.0,0,0.7391103316740528
Signaling by NOTCH2,200,0.11033075205268685,0.21118769483262875,0.0,0,0.6290560622845343
Pre_NOTCH Transcription and Translation,200,0.30372089714225253,2.5825671948114293,0.0,0,0.694282707308086
Pre_NOTCH Expression and Processing,200,0.5260967898410114,3.7558000285618784,0.0,0,0.7552383445534737
Pre_NOTCH Processing in Golgi,150,0.2951688500024806,3.6610879281657582,0.0,0,0.6653971907112612
NRIF signals cell death from the nucleus,100,-0.0,0.0,0.0,0,0.5
p75NTR signals via NF_kB,300,0.15602017223460685,1.4757432350464903,0.0,0,0.6868499188835778
TRAF6 mediated induction of TAK1 complex,1450,0.06372083653729702,0.12083843165987536,0.0,0,0.8048483710090721
Budding and maturation of HIV virion,100,-0.0,0.0,0.0,0,0.5
Endosomal Sorting Complex Required For Transport ESCRT,100,-0.0,0.0,0.0,0,0.5
PinkslashParkin Mediated Mitophagy,100,-0.0,0.0,0.0,0,0.5
Mitophagy,100,-0.0,0.0,0.0,0,0.5
Fanconi Anemia Pathway,100,-0.0,0.0,0.0,0,0.5
Oncogene Induced Senescence,1200,0.05242864644126107,0.32431923181815214,0.0,0,0.7874326999219586
G1 Phase,1000,0.09275471760447733,0.7234221421896292,0.0,0,0.781029258053793
Cyclin D associated events in G1,1000,0.09275471760447733,0.7234221421896292,0.0,0,0.781029258053793
SMAD2slashSMAD3:SMAD4 heterotrimer regulates transcription,200,0.9172475272923584,6.873804815027052,0.034482758620689655,200,0.834473026291418
Transcriptional activity of SMAD2slashSMAD3:SMAD4 heterotrimer,200,0.6359678461996972,5.764603948209603,0.0,0,0.7807058792798343
Signaling by TGF_beta Receptor Complex,450,0.3011260645497226,2.7987895907411815,0.0,0,0.76292581356384
Downregulation of SMAD2slash3:SMAD4 transcriptional activity,450,0.35070943964392876,4.171437025074348,0.0,0,0.7743940846063117
Oxygen_dependent proline hydroxylation of Hypoxia_inducible Factor Alpha,950,0.056514478390006714,0.5652440829200656,0.0,0,0.7684946399804349
Regulation of Hypoxia_inducible Factor HIF by oxygen,950,0.11947040097797544,0.8667880188395558,0.0,0,0.7826199717476654
Cellular response to hypoxia,950,0.11947040097797544,0.8667880188395558,0.0,0,0.7826199717476654
Glycogen synthesis,300,0.19269601338799922,2.3284355580436196,0.0,0,0.6981269010684539
Glycogen breakdown glycogenolysis,550,0.2996929911535368,3.1085495511954195,0.0,0,0.778475443097151
Glucose metabolism,650,5.217219868644756,85.20267840054908,0.9655172413793104,150,0.9984723571705456
Gluconeogenesis,1300,2.396284352808053,41.4223195667711,0.8620689655172413,150,0.9802291515704493
Glycolysis,750,5.701965662039173,107.56501883110887,0.9655172413793104,150,0.9991067823629095
DARPP_32 events,1450,0.06882285006695776,0.5194217806824689,0.0,0,0.8058415016232943
Negative regulation of MAPK pathway,1500,0.15407423435678116,1.1017722689092313,0.0,0,0.8240896133980041
RAF activation,900,0.1841207636289789,2.201131508417386,0.0,0,0.7920411644234762
CTLA4 inhibitory signaling,1500,0.26042306652797376,2.84674655619581,0.0,0,0.8418370443888685
Platelet sensitization by LDL,550,0.2996929911535368,3.2986319861793443,0.0,0,0.778475443097151
S33 mutants of beta_catenin aren t phosphorylated,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
S45 mutants of beta_catenin aren t phosphorylated,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
T41 mutants of beta_catenin aren t phosphorylated,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
S37 mutants of beta_catenin aren t phosphorylated,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
Misspliced GSK3beta mutants stabilize beta_catenin,750,0.25314381213739,2.6119367850109754,0.0,0,0.7923410985653682
Beta_catenin phosphorylation cascade,750,0.25314381213739,2.348199095616959,0.0,0,0.7923410985653682
Disassembly of the destruction complex and recruitment of AXIN to the membrane,800,0.1954272378305977,2.1595376621933995,0.0,0,0.785164204450542
Signaling by WNT in cancer,750,0.25314381213739,2.81471480367554,0.0,0,0.7923410985653682
Spry regulation of FGF signaling,1500,0.13002790000111852,0.8749381256486011,0.0,0,0.8198083453163852
Negative regulation of FGFR4 signaling,1500,0.1043497372243159,0.42859995806641876,0.0,0,0.8151214366043058
Negative regulation of FGFR3 signaling,1500,0.1043497372243159,0.4948798005233683,0.0,0,0.8151214366043058
Negative regulation of FGFR2 signaling,1500,0.1043497372243159,0.4948798005233683,0.0,0,0.8151214366043058
Negative regulation of FGFR1 signaling,1500,0.13002790000111852,0.6088395195342723,0.0,0,0.8198083453163852
FGFR2 ligand binding and activation,100,-0.0,0.0,0.0,0,0.5
Activated point mutants of FGFR2,100,-0.0,0.0,0.0,0,0.5
FGFR1 ligand binding and activation,100,-0.0,0.0,0.0,0,0.5
SHC_mediated cascade:FGFR1,800,0.0675301427132985,0.6588922007777087,0.0,0,0.7558528567073262
SHC_mediated cascade:FGFR2,800,0.02764054316806752,0.16788547628333778,0.0,0,0.7459170751916115
SHC_mediated cascade:FGFR4,800,0.01520921727177638,0.06366776937313827,0.0,0,0.7427387732254271
SHC_mediated cascade:FGFR3,800,0.047169876639660914,0.4701192257958924,0.0,0,0.7508310062821557
Signaling by FGFR3 point mutants in cancer,1200,0.07604818788844754,0.545979957867824,0.0,0,0.792394612350046
Signaling by FGFR3 in disease,1200,0.07604818788844754,0.545979957867824,0.0,0,0.792394612350046
FGFR2 mutant receptor activation,750,0.25314381213739,2.330324540498598,0.0,0,0.7923410985653682
Signaling by FGFR2 in disease,750,0.25314381213739,2.4192783297692984,0.0,0,0.7923410985653682
Signaling by FGFR in disease,750,0.25314381213739,2.29226679382369,0.0,0,0.7923410985653682
Signaling by FGFR1 in disease,1500,0.1043497372243159,0.7686584750367849,0.0,0,0.8151214366043058
FGFR1 mutant receptor activation,1500,0.06297879021735711,0.18847522965976987,0.0,0,0.8073124158287749
Signaling by cytosolic FGFR1 fusion mutants,1500,0.06957634167270539,0.39939485934816715,0.0,0,0.8085794976652525
PI3KslashAKT Signaling in Cancer,1450,0.06882285006695776,0.5085261582098453,0.0,0,0.8058415016232943
Constitutive Signaling by Aberrant PI3K in Cancer,1200,0.017192089484409326,0.07117932194011335,0.0,0,0.7798090330481571
PI5P PP2A and IER3 Regulate PI3KslashAKT Signaling,1500,0.08112239478751182,0.6408970387190822,0.0,0,0.8107769386553485
Negative regulation of the PI3KslashAKT network,1500,0.1043497372243159,0.5829732840818653,0.0,0,0.8151214366043058
CLEC7A Dectin_1 signaling,1500,0.31483894963528014,2.416669042205827,0.0,0,0.8502136443650359
Downstream TCR signaling,1450,0.09804541381328166,0.5716921838284612,0.0,0,0.8114332107624391
Metabolism of polyamines,1500,0.10104582710258099,0.6143003731431679,0.0,0,0.8145096042844681
Hedgehog  on  state,1450,0.06882285006695776,0.5063116437845553,0.0,0,0.8058415016232943
Hedgehog  off  state,100,-0.0,0.0,0.0,0,0.5
TNFR2 non_canonical NF_kB pathway,800,0.1954272378305977,2.66672672359317,0.0,0,0.785164204450542
Degradation of beta_catenin by the destruction complex,800,0.18490992308784407,1.8481123167628573,0.0,0,0.782892785092095
Antigen processing_Cross presentation,1500,0.1043497372243159,0.7870442846728565,0.0,0,0.8151214366043058
ER_Phagosome pathway,1450,0.06882285006695776,0.3495762549362562,0.0,0,0.8058415016232943
Autodegradation of Cdh1 by Cdh1:APCslashC,950,0.1627093614634903,1.6113182562855135,0.0,0,0.7918189479535302
APCslashC:Cdc20 mediated degradation of Securin,950,0.1627093614634903,1.5687340496140822,0.0,0,0.7918189479535302
APCslashC:Cdh1 mediated degradation of Cdc20 and other APCslashC:Cdh1 targeted proteins in late mitosisslashearly G1,950,0.1627093614634903,1.516521667070843,0.0,0,0.7918189479535302
APCslashC_mediated degradation of cell cycle proteins,1500,0.13002790000111852,1.3194008746414592,0.0,0,0.8198083453163852
Regulation of mitotic cell cycle,1500,0.13002790000111852,1.3194008746414592,0.0,0,0.8198083453163852
Regulation of APCslashC activators between G1slashS and early anaphase,950,0.16005018463530285,1.4392094669424078,0.0,0,0.7912646210238446
Activation of APCslashC and APCslashC:Cdc20 mediated degradation of mitotic proteins,950,0.1627093614634903,1.530042203070897,0.0,0,0.7918189479535302
APCslashC:Cdc20 mediated degradation of mitotic proteins,950,0.1627093614634903,1.530042203070897,0.0,0,0.7918189479535302
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,950,0.1627093614634903,1.5687340496140822,0.0,0,0.7918189479535302
Cdc20:Phospho_APCslashC mediated degradation of Cyclin A,950,0.1627093614634903,1.5687340496140822,0.0,0,0.7918189479535302
Regulation of RAS by GAPs,1450,0.06882285006695776,0.4797895091952946,0.0,0,0.8058415016232943
Activation of NF_kappaB in B cells,950,0.1706012552461307,1.9952626315501703,0.0,0,0.7934554247596965
Dectin_1 mediated noncanonical NF_kB signaling,950,0.11947040097797544,1.0250731312902572,0.0,0,0.7826199717476654
NIK__>noncanonical NF_kB signaling,950,0.12564231685883143,1.1324060935565368,0.0,0,0.7839574912215851
Degradation of GLI1 by the proteasome,1450,0.06372083653729702,0.3059000685118792,0.0,0,0.8048483710090721
GLI3 is processed to GLI3R by the proteasome,1450,0.06372083653729702,0.3059000685118792,0.0,0,0.8048483710090721
Degradation of GLI2 by the proteasome,1450,0.06372083653729702,0.3059000685118792,0.0,0,0.8048483710090721
SCF_beta_TrCP mediated degradation of Emi1,1450,0.06882285006695776,0.4656167992954715,0.0,0,0.8058415016232943
Vpu mediated degradation of CD4,1500,0.10104582710258099,0.9093409249106005,0.0,0,0.8145096042844681
CDK_mediated phosphorylation and removal of Cdc6,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Ubiquitin_dependent degradation of Cyclin D1,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Ubiquitin_dependent degradation of Cyclin D,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Regulation of activated PAK_2p34 by proteasome mediated degradation,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Regulation of Apoptosis,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Autodegradation of the E3 ubiquitin ligase COP1,1450,0.06882285006695776,0.41676176567815915,0.0,0,0.8058415016232943
Stabilization of p53,1450,0.06574159083639568,0.33791423601379506,0.0,0,0.8052423263248247
p53_Independent DNA Damage Response,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
p53_Independent G1slashS DNA damage checkpoint,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,1450,0.06882285006695776,0.5011422645026985,0.0,0,0.8058415016232943
Vif_mediated degradation of APOBEC3G,1200,0.0750889538528962,0.4909221218690549,0.0,0,0.7921953746537357
AUF1 hnRNP D0 binds and destabilizes mRNA,1450,0.06372083653729702,0.3059000685118792,0.0,0,0.8048483710090721
Degradation of AXIN,1500,0.09124997924442099,0.8360784634204911,0.0,0,0.8126836397549246
Degradation of DVL,1450,0.08647366508900652,0.7837309710171189,0.0,0,0.8092384893677493
Hh mutants that don t undergo autocatalytic processing are degraded by ERAD,950,0.16005018463530285,1.3543560212622971,0.0,0,0.7912646210238446
Hh mutants abrogate ligand secretion,950,0.16005018463530285,1.3543560212622971,0.0,0,0.7912646210238446
Hedgehog ligand biogenesis,950,0.1706012552461307,1.6800752847074678,0.0,0,0.7934554247596965
The role of GTSE1 in G2slashM progression after G2 checkpoint,1450,0.07001558933766029,0.5392757512333569,0.0,0,0.8060729440363833
Cross_presentation of soluble exogenous antigens endosomes,1450,0.07001558933766029,0.5426008892329233,0.0,0,0.8060729440363833
Regulation of ornithine decarboxylase ODC,1500,0.13002790000111852,1.2309789443178283,0.0,0,0.8198083453163852
G1slashS DNA Damage Checkpoints,1450,0.06882285006695776,0.47611125387134223,0.0,0,0.8058415016232943
p53_Dependent G1slashS DNA damage checkpoint,1450,0.06882285006695776,0.47611125387134223,0.0,0,0.8058415016232943
p53_Dependent G1 DNA Damage Response,1450,0.06882285006695776,0.47611125387134223,0.0,0,0.8058415016232943
SCFSkp2_mediated degradation of p27slashp21,1150,0.10913982413415046,0.9044848230582148,0.0,0,0.7958161345719641
Cyclin A:Cdk2_associated events at S phase entry,1200,0.0750889538528962,0.6082098918383747,0.0,0,0.7921953746537357
Cyclin E associated events during G1slashS transition,1200,0.07604818788844754,0.6459118051075017,0.0,0,0.792394612350046
Synthesis of DNA,950,0.12564231685883143,1.3829489472671634,0.0,0,0.7839574912215851
DNA Replication Pre_Initiation,950,0.12564231685883143,1.1194032071613043,0.0,0,0.7839574912215851
MslashG1 Transition,950,0.12564231685883143,1.1194032071613043,0.0,0,0.7839574912215851
Regulation of DNA replication,950,0.14418713355381077,1.573960912030072,0.0,0,0.7879270389146873
Removal of licensing factors from origins,950,0.1627093614634903,1.625276349380242,0.0,0,0.7918189479535302
Switching of origins to a post_replicative state,950,0.1627093614634903,1.625276349380242,0.0,0,0.7918189479535302
Orc1 removal from chromatin,950,0.1627093614634903,1.625276349380242,0.0,0,0.7918189479535302
Assembly of the pre_replicative complex,950,0.1627093614634903,1.4500632185382276,0.0,0,0.7918189479535302
CDT1 association with the CDC6:ORC:origin complex,950,0.16005018463530285,1.3543560212622971,0.0,0,0.7912646210238446
Regulation of mRNA stability by proteins that bind AU_rich elements,1500,0.10104582710258099,0.6843962967702869,0.0,0,0.8145096042844681
MAPK6slashMAPK4 signaling,950,0.12564231685883143,1.0229278648110771,0.0,0,0.7839574912215851
Asymmetric localization of PCP proteins,1450,0.06574159083639568,0.33791423601379506,0.0,0,0.8052423263248247
PCPslashCE pathway,1200,0.0750889538528962,0.5369376203326923,0.0,0,0.7921953746537357
Deactivation of the beta_catenin transactivating complex,1500,0.09124997924442099,0.6149543185827265,0.0,0,0.8126836397549246
APCslashC:Cdc20 mediated degradation of Cyclin B,400,0.3236235630530724,4.218281782687659,0.0,0,0.7588258160855381
Phosphorylation of the APCslashC,350,0.4076052629771625,5.574343644176686,0.0,0,0.7682754725309424
Conversion from APCslashC:Cdc20 to APCslashC:Cdh1 in late anaphase,350,0.4076052629771625,5.541285175922926,0.0,0,0.7682754725309424
Mitotic Spindle Checkpoint,350,0.4076052629771625,5.541285175922926,0.0,0,0.7682754725309424
Inhibition of the proteolytic activity of APCslashC required for the onset of anaphase by mitotic spindle checkpoint components,350,0.4076052629771625,5.541285175922926,0.0,0,0.7682754725309424
Inactivation of APCslashC via direct inhibition of the APCslashC complex,350,0.4076052629771625,5.541285175922926,0.0,0,0.7682754725309424
APC_Cdc20 mediated degradation of Nek2A,450,0.3011260645497226,3.9620367921031097,0.0,0,0.76292581356384
Resolution of Sister Chromatid Cohesion,550,0.2996929911535368,3.999568772714159,0.0,0,0.778475443097151
PTK6 Regulates RHO GTPases RAS GTPase and MAP kinases,100,-0.0,0.0,0.0,0,0.5
Signaling by PTK6,1450,0.06574159083639568,0.33152880058831774,0.0,0,0.8052423263248247
ERBB2 Regulates Cell Motility,100,-0.0,0.0,0.0,0,0.5
PI3K events in ERBB2 signaling,1450,0.06882285006695776,0.4681317375441296,0.0,0,0.8058415016232943
GRB2 events in ERBB2 signaling,800,0.08134033122299195,0.8812642080958095,0.0,0,0.7592013995566073
SHC1 events in ERBB2 signaling,800,0.0675301427132985,0.6588922007777087,0.0,0,0.7558528567073262
Signaling by ERBB2,1350,0.1031389028070214,0.6215473930875719,0.0,0,0.8070268720616478
Constitutive Signaling by Ligand_Responsive EGFR Cancer Variants,1200,0.04641480648765999,0.3120016276729897,0.0,0,0.7861505025995329
Signaling by Ligand_Responsive EGFR Variants in Cancer,1200,0.04641480648765999,0.3120016276729897,0.0,0,0.7861505025995329
Signaling by EGFR in Cancer,1200,0.04641480648765999,0.3120016276729897,0.0,0,0.7861505025995329
Signaling by EGFRvIII in Cancer,1450,0.06882285006695776,0.5169941339243171,0.0,0,0.8058415016232943
Constitutive Signaling by EGFRvIII,1450,0.06882285006695776,0.5169941339243171,0.0,0,0.8058415016232943
Tie2 Signaling,1200,0.06841073516763335,0.4458721861638263,0.0,0,0.7908029656910424
TRAF6 mediated IRF7 activation,1200,0.041316534441554975,0.2014660735632714,0.0,0,0.7850574557272785
RIG_IslashMDA5 mediated induction of IFN_alphaslashbeta pathways,250,0.22254884832195634,1.6544234552626906,0.0,0,0.6898749131349897
Negative regulators of RIG_IslashMDA5 signaling,1200,0.06841073516763335,0.5000411926153215,0.0,0,0.7908029656910424
Diseases associated with the TLR signaling cascade,400,0.3986271721978402,5.1007399700579645,0.0,0,0.7762530293394193
Diseases of Immune System,400,0.3986271721978402,5.1007399700579645,0.0,0,0.7762530293394193
Cytosolic sensors of pathogen_associated DNA,450,0.17630305411643743,1.6947664611934454,0.0,0,0.7314072946914469
ZBP1DAI mediated induction of type I IFNs,450,0.21230738574235372,2.2771776676189726,0.0,0,0.7409057762254165
RIP_mediated NFkB activation via ZBP1,450,0.2867462026545792,2.8714964506108935,0.0,0,0.7594920904405257
TRAF6 mediated NF_kB activation,450,0.21986850325110646,2.6681908356443254,0.0,0,0.7428574304556514
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,450,0.17630305411643743,2.0766199748649448,0.0,0,0.7314072946914469
JNK c_Jun kinases phosphorylation and  activation mediated by activated human TAK1,100,-0.0,0.0,0.0,0,0.5
activated TAK1 mediates p38 MAPK activation,100,-0.0,0.0,0.0,0,0.5
NOD1slash2 Signaling Pathway,1450,0.023927013792192857,0.03457310495104169,0.0,0,0.7969259555106203
Nucleotide_binding domain leucine rich repeat containing receptor NLR signaling pathways,100,-0.0,0.0,0.0,0,0.5
Interleukin_1 signaling,1450,0.0003460141187616417,0.0003460141187616417,0.0,0,0.7920803590659582
MAP3K8 TPL2_dependent MAPK1slash3 activation,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
MyD88_independent TLR3slashTLR4 cascade,400,0.3986271721978402,3.9404814675728295,0.0,0,0.7762530293394193
Toll Like Receptor 3 TLR3 Cascade,400,0.3986271721978402,3.9404814675728295,0.0,0,0.7762530293394193
TRIF_mediated TLR3slashTLR4 signaling,400,0.3986271721978402,3.9404814675728295,0.0,0,0.7762530293394193
MyD88:Mal cascade initiated on plasma membrane,1200,0.06841073516763335,0.5311471372756447,0.0,0,0.7908029656910424
Toll Like Receptor TLR1:TLR2 Cascade,1200,0.06841073516763335,0.5311471372756447,0.0,0,0.7908029656910424
Toll Like Receptor TLR6:TLR2 Cascade,1200,0.06841073516763335,0.5311471372756447,0.0,0,0.7908029656910424
Toll Like Receptor 2 TLR2 Cascade,1200,0.06841073516763335,0.5311471372756447,0.0,0,0.7908029656910424
Toll Like Receptor 9 TLR9 Cascade,550,0.17666228052338745,1.7842850460478887,0.0,0,0.7494736360369059
MyD88 dependent cascade initiated on endosome,400,0.18357434197872663,1.8861882270858643,0.0,0,0.7225700002158365
Toll Like Receptor 7slash8 TLR7slash8 Cascade,400,0.18357434197872663,1.8861882270858643,0.0,0,0.7225700002158365
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7slash8 or 9 activation,400,0.19754413904318546,1.9527103241905097,0.0,0,0.7264186956742718
Toll Like Receptor 10 TLR10 Cascade,550,0.091858109059615,0.9440640889709582,0.0,0,0.7273010793551272
Toll Like Receptor 5 TLR5 Cascade,550,0.091858109059615,0.9440640889709582,0.0,0,0.7273010793551272
MyD88 cascade initiated on plasma membrane,550,0.091858109059615,0.9440640889709582,0.0,0,0.7273010793551272
TRAF6 Mediated Induction of proinflammatory cytokines,550,0.1393035858202627,1.5864568179430585,0.0,0,0.7399372741853882
MAP kinase activation in TLR cascade,1500,0.09124997924442099,0.4756833078076679,0.0,0,0.8126836397549246
MAPK targetsslash Nuclear events mediated by MAP kinases,1500,0.15407423435678116,1.603802871533295,0.0,0,0.8240896133980041
Nuclear Events kinase and transcription factor activation,1500,0.28977693676947824,2.1814139701937814,0.0,0,0.8464122605986615
ERKslashMAPK targets,1500,0.31483894963528014,2.6863798962435808,0.0,0,0.8502136443650359
Activation of IRF3slashIRF7 mediated by TBK1slashIKK epsilon,250,0.5058046712322952,4.5808125826025385,0.0,0,0.7663743847658283
IKK complex recruitment mediated by RIP1,100,-0.0,0.0,0.0,0,0.5
Caspase activation via extrinsic apoptotic signalig pathway,200,0.1630169048464013,0.9192249893485147,0.0,0,0.6480937562572824
Ligand_dependent caspase activation,200,0.24340389289311207,2.261909076610417,0.0,0,0.6752752829080466
Regulated Necrosis,1500,0.1043497372243159,0.33706222866913194,0.0,0,0.8151214366043058
RIPK1_mediated regulated necrosis,1500,0.1043497372243159,0.33706222866913194,0.0,0,0.8151214366043058
TNFR1_induced NFkappaB signaling pathway,1450,0.06372083653729702,0.1304660184954478,0.0,0,0.8048483710090721
Regulation of TNFR1 signaling,1250,0.03787351632923858,0.1650511025118097,0.0,0,0.7877130375324649
TNF signaling,1450,0.06882285006695776,0.25676284146185835,0.0,0,0.8058415016232943
Death Receptor Signalling,1500,0.1043497372243159,0.4050931366413674,0.0,0,0.8151214366043058
Anchoring of the basal body to the plasma membrane,1500,0.10104582710258099,0.3815254642077244,0.0,0,0.8145096042844681
Centrosome maturation,1400,0.006044959587681393,0.011411912099090017,0.0,0,0.7903742946098833
Recruitment of mitotic centrosome proteins and complexes,1400,0.006044959587681393,0.011411912099090017,0.0,0,0.7903742946098833
Loss of Nlp from mitotic centrosomes,1350,0.026509311788801372,0.10922589249245358,0.0,0,0.7916580882232037
Loss of proteins required for interphase microtubule organizationfrom the centrosome,1350,0.026509311788801372,0.10922589249245358,0.0,0,0.7916580882232037
AURKA Activation by TPX2,1450,0.06574159083639568,0.224879920331013,0.0,0,0.8052423263248247
Regulation of PLK1 Activity at G2slashM Transition,1450,0.041204960094945106,0.13900219866241026,0.0,0,0.8004045201831624
Polo_like kinase mediated events,100,-0.0,0.0,0.0,0,0.5
Cyclin AslashB1 associated events during G2slashM transition,800,0.01520921727177638,0.026313377149554035,0.0,0,0.7427387732254271
WNT ligand biogenesis and trafficking,100,-0.0,0.0,0.0,0,0.5
Negative regulation of TCF_dependent signaling by WNT ligand antagonists,100,-0.0,0.0,0.0,0,0.5
Regulation of FZD by ubiquitination,100,-0.0,0.0,0.0,0,0.5
Adherens junctions interactions,1450,0.041204960094945106,0.18688245858779204,0.0,0,0.8004045201831624
Cell_cell junction organization,1500,0.13002790000111852,1.1908257567819955,0.0,0,0.8198083453163852
Cell junction organization,1500,0.09124997924442099,0.36566052168345153,0.0,0,0.8126836397549246
Tight junction interactions,1500,0.17568908709484918,2.1173178609098287,0.0,0,0.8278510921485196
Cell_extracellular matrix interactions,100,-0.0,0.0,0.0,0,0.5
Basigin interactions,100,-0.0,0.0,0.0,0,0.5
Nephrin interactions,100,-0.0,0.0,0.0,0,0.5
Netrin_1 signaling,100,-0.0,0.0,0.0,0,0.5
Regulation of KIT signaling,150,0.3150697373977847,4.773464653660231,0.0,0,0.6719902619619795
CD209 DC_SIGN signaling,1200,0.34351445955689874,5.160444194575176,0.0,0,0.8411162454527079
Rap1 signalling,1500,0.28977693676947824,2.8458937769841866,0.0,0,0.8464122605986615
MAP2K and MAPK activation,950,0.1627093614634903,2.535248879952191,0.0,0,0.7918189479535302
GRB2:SOS provides linkage to MAPK signaling for Integrins,950,0.1627093614634903,1.830145458922199,0.0,0,0.7918189479535302
p130Cas linkage to MAPK signaling for integrins,1200,0.10836769743018664,0.8072296990640304,0.0,0,0.798997048207853
Integrin alphaIIb beta3 signaling,1350,1.1865624731515512,6.849483968649581,0.13793103448275862,1350,0.9346911617584392
Platelet Aggregation Plug Formation,1350,0.732958859959831,4.950165696993,0.034482758620689655,1350,0.8972055885128216
Other semaphorin interactions,1200,0.017192089484409326,0.07230949382317406,0.0,0,0.7798090330481571
Semaphorin interactions,100,-0.0,0.0,0.0,0,0.5
CRMPs in Sema3A signaling,100,-0.0,0.0,0.0,0,0.5
Sema3A PAK dependent Axon repulsion,800,0.01520921727177638,0.06366776937313827,0.0,0,0.7427387732254271
Ephrin signaling,250,0.7953013582342092,6.0932192623295,0.034482758620689655,250,0.8250984555961187
EPHB_mediated forward signaling,250,0.24220308143809638,1.5966688609046722,0.0,0,0.6959106754531759
EPH_Ephrin signaling,250,0.22254884832195634,0.8718148410395701,0.0,0,0.6898749131349897
EPH_ephrin mediated repulsion of cells,200,0.30372089714225253,2.6638433143605638,0.0,0,0.694282707308086
EPHA_mediated growth cone collapse,1500,0.13002790000111852,0.8718141351813942,0.0,0,0.8198083453163852
RHO GTPases activate PAKs,450,0.11282069244790063,1.6041146092986334,0.0,0,0.713803543113883
RHO GTPases activate CIT,100,-0.0,0.0,0.0,0,0.5
RHO GTPases Activate ROCKs,800,0.0126922472773355,0.019641711279961095,0.0,0,0.7420904388601046
Sema4D induced cell migration and growth_cone collapse,100,-0.0,0.0,0.0,0,0.5
Sema4D in semaphorin signaling,100,-0.0,0.0,0.0,0,0.5
Signaling by Robo receptor,750,0.20762448832289396,2.419299887860769,0.0,0,0.7826701684857847
Myogenesis,1500,0.1043497372243159,0.7034442127809519,0.0,0,0.8151214366043058
CDO in myogenesis,1500,0.1043497372243159,0.7034442127809519,0.0,0,0.8151214366043058
RHO GTPases Activate WASPs and WAVEs,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Regulation of actin dynamics for phagocytic cup formation,850,0.06553782662362957,0.40634611361716005,0.0,0,0.7608046552638016
Role of phospholipids in phagocytosis,950,0.12735392784893831,1.3655563198328882,0.0,0,0.7843269556740329
FCGR activation,1500,0.26042306652797376,1.9854838174353864,0.0,0,0.8418370443888685
Classical antibody_mediated complement activation,100,-0.0,0.0,0.0,0,0.5
Creation of C4 and C2 activators,100,-0.0,0.0,0.0,0,0.5
Initial triggering of complement,100,-0.0,0.0,0.0,0,0.5
Complement cascade,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Binding and Uptake of Ligands by Scavenger Receptors,1200,0.07727954608422131,0.6855890807403795,0.0,0,0.7926500916200884
Scavenging of heme from plasma,100,-0.0,0.0,0.0,0,0.5
FCERI mediated Ca+2 mobilization,1500,0.10805602624799676,0.7356250375678879,0.0,0,0.815805381762395
CD22 mediated BCR regulation,1500,0.13002790000111852,1.3601614502425932,0.0,0,0.8198083453163852
Antigen activates B Cell Receptor BCR leading to generation of second messengers,1500,0.17568908709484918,1.4514254038568073,0.0,0,0.8278510921485196
Regulation of Complement cascade,800,0.02764054316806752,0.16788547628333778,0.0,0,0.7459170751916115
Metabolism of Angiotensinogen to Angiotensins,800,0.035759141494791716,0.29549119171696087,0.0,0,0.7479715215033013
Regulation of Insulin_like Growth Factor IGF transport and uptake by Insulin_like Growth Factor Binding Proteins IGFBPs,100,-0.0,0.0,0.0,0,0.5
Synthesis secretion and inactivation of Glucagon_like Peptide_1 GLP_1,450,0.21230738574235372,2.769933689378299,0.0,0,0.7409057762254165
Incretin synthesis secretion and inactivation,450,0.21230738574235372,2.769933689378299,0.0,0,0.7409057762254165
Synthesis secretion and deacylation of Ghrelin,950,0.1627093614634903,1.348172795098952,0.0,0,0.7918189479535302
Peptide hormone metabolism,800,0.1954272378305977,1.9879566605102066,0.0,0,0.785164204450542
Insulin processing,800,0.0970227383074923,0.722999195059598,0.0,0,0.7629482446683584
VxPx cargo_targeting to cilium,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
Cargo trafficking to the periciliary membrane,1450,0.041204960094945106,0.17225337062069745,0.0,0,0.8004045201831624
BBSome_mediated cargo_targeting to cilium,1450,0.06882285006695776,0.21827384212981357,0.0,0,0.8058415016232943
Cooperation of PDCL PhLP1 and TRiCslashCCT in G_protein beta folding,1500,0.1345810051353416,0.978375024870854,0.0,0,0.8206269119403945
Chaperonin_mediated protein folding,1450,0.06882285006695776,0.29805151667182317,0.0,0,0.8058415016232943
Association of TriCslashCCT with target proteins during biosynthesis,150,0.0927286166945884,0.4312557230110744,0.0,0,0.5903167018035448
Prefoldin mediated transfer of substrate  to CCTslashTriC,1350,0.10739780895182353,0.6717246877566023,0.0,0,0.8078469788834046
Cooperation of Prefoldin and TriCslashCCT  in actin and tubulin folding,1350,0.1031389028070214,0.6240108965758118,0.0,0,0.8070268720616478
Formation of tubulin folding intermediates by CCTslashTriC,1350,0.1031389028070214,0.5451634145756213,0.0,0,0.8070268720616478
Post_chaperonin tubulin folding pathway,100,-0.0,0.0,0.0,0,0.5
Regulation of signaling by CBL,1500,0.13002790000111852,1.0216416238936705,0.0,0,0.8198083453163852
GPVI_mediated activation cascade,1450,0.06882285006695776,0.45795592033449495,0.0,0,0.8058415016232943
G beta:gamma signalling through PI3Kgamma,1450,0.06882285006695776,0.2309444220432714,0.0,0,0.8058415016232943
G_protein beta:gamma signalling,1500,0.10104582710258099,0.5966793234109496,0.0,0,0.8145096042844681
Class Bslash2 Secretin family receptors,1450,0.06882285006695776,0.4883809608601224,0.0,0,0.8058415016232943
Ca2+ pathway,1500,0.19270289616245093,1.487861189723824,0.0,0,0.8307552255576883
Activation of Kainate Receptors upon glutamate binding,800,0.10531717060413566,0.9308065478653194,0.0,0,0.7649063226054068
Presynaptic function of Kainate receptors,1500,0.13002790000111852,1.1525668863421976,0.0,0,0.8198083453163852
G beta:gamma signalling through PLC beta,1500,0.13002790000111852,1.1525668863421976,0.0,0,0.8198083453163852
Prostacyclin signalling through prostacyclin receptor,1450,0.06882285006695776,0.2031583212290373,0.0,0,0.8058415016232943
ADP signalling through P2Y purinoceptor 12,1450,0.06882285006695776,0.19648665535944435,0.0,0,0.8058415016232943
G_protein activation,1450,0.06372083653729702,0.15973771321762648,0.0,0,0.8048483710090721
Adrenalinenoradrenaline inhibits insulin secretion,1450,0.06882285006695776,0.2031583212290373,0.0,0,0.8058415016232943
Signal amplification,950,0.1627093614634903,1.5371993583503443,0.0,0,0.7918189479535302
ADP signalling through P2Y purinoceptor 1,800,0.1954272378305977,2.0141357332702676,0.0,0,0.785164204450542
Thromboxane signalling through TP receptor,800,0.1101896041443778,1.0271299426084932,0.0,0,0.7660490148176294
Thrombin signalling through proteinase activated receptors PARs,800,0.1954272378305977,2.811108178347319,0.0,0,0.785164204450542
Glucagon_type ligand receptors,1450,0.06882285006695776,0.2031583212290373,0.0,0,0.8058415016232943
Glucagon_like Peptide_1 GLP1 regulates insulin secretion,1400,0.00993934786391315,0.013953631049441917,0.0,0,0.791189070941895
Regulation of insulin secretion,1450,0.06882285006695776,0.5784725334518453,0.0,0,0.8058415016232943
Opioid Signalling,800,0.1101896041443778,0.8926297952973389,0.0,0,0.7660490148176294
Glucagon signaling in metabolic regulation,1450,0.041204960094945106,0.10480415229660309,0.0,0,0.8004045201831624
Vasopressin regulates renal water homeostasis via Aquaporins,1450,0.06882285006695776,0.2759052815515334,0.0,0,0.8058415016232943
Aquaporin_mediated transport,1450,0.06882285006695776,0.24081274307382156,0.0,0,0.8058415016232943
G alpha z signalling events,1450,0.044522820945218415,0.13023260098782236,0.0,0,0.8010656528319821
GABA receptor activation,1450,0.031487322306724116,0.0802216480409139,0.0,0,0.7984554688565138
GABA B receptor activation,1450,0.031487322306724116,0.0802216480409139,0.0,0,0.7984554688565138
Activation of GABAB receptors,1450,0.031487322306724116,0.0802216480409139,0.0,0,0.7984554688565138
Activation of G protein gated Potassium channels,1450,0.06882285006695776,0.19648665535944435,0.0,0,0.8058415016232943
Inhibition  of voltage gated Ca2+ channels via Gbetaslashgamma subunits,1450,0.06882285006695776,0.19648665535944435,0.0,0,0.8058415016232943
G protein gated Potassium channels,1450,0.06882285006695776,0.19648665535944435,0.0,0,0.8058415016232943
Inwardly rectifying K+ channels,1450,0.10896379234604296,0.7204981982555012,0.0,0,0.813480855523966
Potassium Channels,1500,0.10104582710258099,1.1042100260303283,0.0,0,0.8145096042844681
Voltage gated Potassium channels,800,0.02764054316806752,0.16788547628333778,0.0,0,0.7459170751916115
Activation of NMDA receptor upon glutamate binding and postsynaptic events,1450,0.041204960094945106,0.07178722980913024,0.0,0,0.8004045201831624
Post NMDA receptor activation events,1450,0.041204960094945106,0.07178722980913024,0.0,0,0.8004045201831624
CREB phosphorylation through the activation of Ras,1450,0.06882285006695776,0.13180164028431487,0.0,0,0.8058415016232943
Ras activation uopn Ca2+ infux through NMDA receptor,1450,0.06882285006695776,0.4473871007981529,0.0,0,0.8058415016232943
CREB phosphorylation through the activation of CaMKII,1450,0.06882285006695776,0.43570206563250413,0.0,0,0.8058415016232943
Unblocking of NMDA receptor glutamate binding and activation,1500,0.08561611212500851,0.5227779958296511,0.0,0,0.8116253459278404
SALM protein interactions at the synapse,100,-0.0,0.0,0.0,0,0.5
Phospholipase C_mediated cascade: FGFR1,800,0.0012036413005548805,0.0012036413005548805,0.0,0,0.7391103316740528
Phospholipase C_mediated cascade FGFR2,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Phospholipase C_mediated cascade FGFR3,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Phospholipase C_mediated cascade FGFR4,100,-0.0,0.0,0.0,0,0.5
EGFR interacts with phospholipase C_gamma,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
DAG and IP3 signaling,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
PLC_gamma1 signalling,800,0.0048054527915894285,0.0048054527915894285,0.0,0,0.740048316842399
CaM pathway,800,0.01520921727177638,0.06366776937313827,0.0,0,0.7427387732254271
Calmodulin induced events,800,0.01520921727177638,0.06366776937313827,0.0,0,0.7427387732254271
Ca_dependent events,800,0.01520921727177638,0.026313377149554035,0.0,0,0.7427387732254271
PLC beta mediated events,800,0.035759141494791716,0.17476679349196148,0.0,0,0.7479715215033013
G_protein mediated events,800,0.035759141494791716,0.17476679349196148,0.0,0,0.7479715215033013
PKA_mediated phosphorylation of CREB,100,-0.0,0.0,0.0,0,0.5
PKA activation,100,-0.0,0.0,0.0,0,0.5
PKA activation in glucagon signalling,100,-0.0,0.0,0.0,0,0.5
The phototransduction cascade,1000,0.09275471760447733,0.6685596356892131,0.0,0,0.781029258053793
Inactivation recovery and regulation of the phototransduction cascade,1000,0.09275471760447733,0.6685596356892131,0.0,0,0.781029258053793
Smooth Muscle Contraction,100,-0.0,0.0,0.0,0,0.5
Striated Muscle Contraction,1500,0.13002790000111852,1.7697425146898884,0.0,0,0.8198083453163852
Ion homeostasis,100,-0.0,0.0,0.0,0,0.5
Ion transport by P_type ATPases,1500,0.09124997924442099,0.6514258183951083,0.0,0,0.8126836397549246
Platelet calcium homeostasis,100,-0.0,0.0,0.0,0,0.5
Elevation of cytosolic Ca2+ levels,100,-0.0,0.0,0.0,0,0.5
Platelet homeostasis,1500,0.10104582710258099,0.9366850686567898,0.0,0,0.8145096042844681
Nitric oxide stimulates guanylate cyclase,1450,0.06882285006695776,0.5346572956047764,0.0,0,0.8058415016232943
cGMP effects,1450,0.06882285006695776,0.5346572956047764,0.0,0,0.8058415016232943
Phase 2 _ plateau phase,1450,0.06882285006695776,0.21827384212981357,0.0,0,0.8058415016232943
Phase 1 _ inactivation of fast Na+ channels,1450,0.06882285006695776,0.21827384212981357,0.0,0,0.8058415016232943
Phase 0 _ rapid depolarisation,1350,0.1031389028070214,0.47447139566674096,0.0,0,0.8070268720616478
NCAM1 interactions,1450,0.025201670625174952,0.08116181349821572,0.0,0,0.7971846403268208
Class Cslash3 Metabotropic glutamateslashpheromone receptors,100,-0.0,0.0,0.0,0,0.5
Chemokine receptors bind chemokines,1500,0.17568908709484918,1.111893726802574,0.0,0,0.8278510921485196
Nucleotide_like purinergic receptors,900,2.104265847255461,26.576482103178947,0.5517241379310345,750,0.9695162098876254
Eicosanoid ligand_binding receptors,1500,0.13002790000111852,0.951010634649457,0.0,0,0.8198083453163852
Amine ligand_binding receptors,100,-0.0,0.0,0.0,0,0.5
eNOS activation and regulation,1500,0.13002790000111852,1.1132978360514074,0.0,0,0.8198083453163852
Metabolism of nitric oxide,1500,0.13002790000111852,1.1132978360514074,0.0,0,0.8198083453163852
Scavenging by Class A Receptors,800,0.08134033122299195,1.1465071233108657,0.0,0,0.7592013995566073
Chylomicron_mediated lipid transport,450,0.35070943964392876,3.850496390084102,0.0,0,0.7743940846063117
Lipoprotein metabolism,450,0.16307212066528914,1.729770298820298,0.0,0,0.7278299488563533
HDL_mediated lipid transport,100,-0.0,0.0,0.0,0,0.5
Lipid digestion mobilization and transport,800,0.047169876639660914,0.2783919959039158,0.0,0,0.7508310062821557
Hormone_sensitive lipase HSL_mediated triacylglycerol hydrolysis,100,-0.0,0.0,0.0,0,0.5
Digestion of dietary lipid,100,-0.0,0.0,0.0,0,0.5
Inositol phosphate metabolism,800,0.1948832143492539,1.801287632593402,0.0,0,0.7850472969357967
Synthesis of IP3 and IP4 in the cytosol,800,0.1948832143492539,1.935526050606688,0.0,0,0.7850472969357967
Synthesis of PIPs at the plasma membrane,1450,0.06882285006695776,0.4227416562012556,0.0,0,0.8058415016232943
PI Metabolism,1450,0.06882285006695776,0.2045826073862229,0.0,0,0.8058415016232943
Synthesis of PIPs at the Golgi membrane,1450,0.06882285006695776,0.15144335156427596,0.0,0,0.8058415016232943
p75 NTR receptor_mediated signalling,800,0.1954272378305977,2.3322526246782074,0.0,0,0.785164204450542
Cell death signalling via NRAGE NRIF and NADE,1000,0.12534770949626203,1.048262676715344,0.0,0,0.7880511163839445
NRAGE signals death through JNK,950,0.1706012552461307,1.7712402229958037,0.0,0,0.7934554247596965
G alpha 12slash13 signalling events,1000,0.09275471760447733,0.7146365919401027,0.0,0,0.781029258053793
Signaling by Hippo,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Apoptotic execution  phase,1500,0.06297879021735711,0.262703541953219,0.0,0,0.8073124158287749
Apoptotic cleavage of cellular proteins,1500,0.09124997924442099,0.317262018081662,0.0,0,0.8126836397549246
Mitochondrial protein import,1500,0.13002790000111852,1.17943726153675,0.0,0,0.8198083453163852
TGF_beta receptor signaling in EMT epithelial to mesenchymal transition,100,-0.0,0.0,0.0,0,0.5
TGF_beta receptor signaling activates SMADs,200,0.0733028027927964,0.16176612075936045,0.0,0,0.6150633061650873
Downregulation of TGF_beta receptor signaling,200,0.1436378101979712,0.6524196221836805,0.0,0,0.6412076238521048
Signaling by BMP,500,0.21596995737229657,2.7580680591148363,0.0,0,0.7510066184501685
Signaling by NODAL,800,0.047169876639660914,0.4717496668259154,0.0,0,0.7508310062821557
Inflammasomes,100,-0.0,0.0,0.0,0,0.5
Ligand_gated ion channel transport,100,-0.0,0.0,0.0,0,0.5
ROS RNS production in response to bacteria,800,0.1101896041443778,1.1516143182543763,0.0,0,0.7660490148176294
Insulin receptor recycling,100,-0.0,0.0,0.0,0,0.5
Transferrin endocytosis and recycling,1450,0.020275054229952297,0.04971333882802872,0.0,0,0.7961829814821922
Iron uptake and transport,1500,0.1043497372243159,0.5136194600065515,0.0,0,0.8151214366043058
TRP channels,1450,0.06882285006695776,0.3181439351651155,0.0,0,0.8058415016232943
Effects of PIP2 hydrolysis,1350,0.1031389028070214,1.0849792341885582,0.0,0,0.8070268720616478
Synthesis of PC,100,-0.0,0.0,0.0,0,0.5
Synthesis of PA,950,0.12564231685883143,1.2749077056444706,0.0,0,0.7839574912215851
Acyl chain remodelling of PG,1450,0.06882285006695776,0.21827384212981357,0.0,0,0.8058415016232943
Acyl chain remodelling of PC,100,-0.0,0.0,0.0,0,0.5
Acyl chain remodelling of PE,100,-0.0,0.0,0.0,0,0.5
Acyl chain remodelling of PS,100,-0.0,0.0,0.0,0,0.5
Acyl chain remodelling of PI,100,-0.0,0.0,0.0,0,0.5
Mitochondrial Fatty Acid Beta_Oxidation,1500,0.13002790000111852,0.9816809778152813,0.0,0,0.8198083453163852
Diseases of metabolism,100,-0.0,0.0,0.0,0,0.5
Defects in vitamin and cofactor metabolism,1450,0.025201670625174952,0.18282389943180566,0.0,0,0.7971846403268208
Cobalamin Cbl vitamin B12 transport and metabolism,100,-0.0,0.0,0.0,0,0.5
Metabolism of water_soluble vitamins and cofactors,1000,0.12534770949626203,0.8295120294253614,0.0,0,0.7880511163839445
Metabolism of folate and pterines,100,-0.0,0.0,0.0,0,0.5
Sulfur amino acid metabolism,100,-0.0,0.0,0.0,0,0.5
Metabolism of steroid hormones,100,-0.0,0.0,0.0,0,0.5
Steroid hormones,800,0.035759141494791716,0.29549119171696087,0.0,0,0.7479715215033013
Amine_derived hormones,100,-0.0,0.0,0.0,0,0.5
Peroxisomal lipid metabolism,800,0.005630737948231035,0.005630737948231035,0.0,0,0.7402627626063285
Synthesis of very long_chain fatty acyl_CoAs,100,-0.0,0.0,0.0,0,0.5
Fatty Acyl_CoA Biosynthesis,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Triglyceride Biosynthesis,800,0.08134033122299195,0.5084563524019947,0.0,0,0.7592013995566073
Transcriptional regulation of white adipocyte differentiation,750,0.25314381213739,3.1714431482208383,0.0,0,0.7923410985653682
Mitochondrial biogenesis,950,0.1627093614634903,1.331464118475485,0.0,0,0.7918189479535302
Transcriptional activation of mitochondrial biogenesis,950,0.1697747011793412,1.5092887807302597,0.0,0,0.7932846339268531
Circadian Clock,1300,0.33272057776381175,3.1185638351081186,0.0,0,0.8443247158076392
BMAL1:CLOCKNPAS2 activates circadian gene expression,1500,0.28977693676947824,3.600807091552419,0.0,0,0.8464122605986615
RORA activates gene expression,950,0.1706012552461307,1.7811321852917232,0.0,0,0.7934554247596965
YAP1_ and WWTR1 TAZ_stimulated gene expression,800,0.0675301427132985,0.5494312676760219,0.0,0,0.7558528567073262
Regulation of cholesterol biosynthesis by SREBP SREBF,400,0.3986271721978402,5.596910438634812,0.0,0,0.7762530293394193
Activation of gene expression by SREBF SREBP,450,0.25825683053096404,3.2120043071901594,0.0,0,0.7525416341402709
Cholesterol biosynthesis,1450,0.06372083653729702,0.28419934861916335,0.0,0,0.8048483710090721
Nuclear Receptor transcription pathway,1500,0.26042306652797376,1.9583267036176073,0.0,0,0.8418370443888685
Recycling of bile acids and salts,800,0.08134033122299195,1.1465071233108657,0.0,0,0.7592013995566073
Bile acid and bile salt metabolism,250,0.24220308143809638,2.798470138603394,0.0,0,0.6959106754531759
Synthesis of bile acids and bile salts,250,0.24220308143809638,3.144458609298446,0.0,0,0.6959106754531759
Synthesis of bile acids and bile salts via 7alpha_hydroxycholesterol,250,0.24220308143809638,3.144458609298446,0.0,0,0.6959106754531759
Synthesis of bile acids and bile salts via 27_hydroxycholesterol,950,0.1627093614634903,1.4250171757971712,0.0,0,0.7918189479535302
Arachidonic acid metabolism,1500,0.26042306652797376,3.74760296898558,0.0,0,0.8418370443888685
Synthesis of Leukotrienes LT and Eoxins EX,1500,0.09124997924442099,0.5522179755847075,0.0,0,0.8126836397549246
Fatty acids,1000,0.12534770949626203,1.034039294630978,0.0,0,0.7880511163839445
Endogenous sterols,950,0.1627093614634903,1.5723443510087856,0.0,0,0.7918189479535302
Cytochrome P450 _ arranged by substrate type,1000,0.13751176623362918,1.3682315654462642,0.0,0,0.7906136575844264
Phase 1 _ Functionalization of compounds,150,0.17371075684381104,1.6523904598021055,0.0,0,0.6221858992698044
Xenobiotics,100,-0.0,0.0,0.0,0,0.5
Aflatoxin activation and detoxification,1450,0.10896379234604296,0.9088670311406073,0.0,0,0.813480855523966
Glutathione conjugation,800,0.0011184085788069518,0.0011184085788069518,0.0,0,0.7390880943898869
Glucuronidation,100,-0.0,0.0,0.0,0,0.5
Cytosolic sulfonation of small molecules,950,0.1627093614634903,1.1950123569429814,0.0,0,0.7918189479535302
Synthesis and interconversion of nucleotide di_ and triphosphates,150,0.2945894421007127,2.60026183265051,0.0,0,0.6652032630234135
Detoxification of Reactive Oxygen Species,450,0.35070943964392876,5.303830358889247,0.0,0,0.7743940846063117
Metabolism of porphyrins,950,0.12564231685883143,1.1284086011819925,0.0,0,0.7839574912215851
Purine metabolism,150,0.13746176051277056,1.1865000161568493,0.0,0,0.6082392687500177
Metabolism of nucleotides,150,0.883607873781705,4.161034371961224,0.034482758620689655,150,0.8142307781338189
Pyrimidine metabolism,1450,0.06882285006695776,0.5169941339243171,0.0,0,0.8058415016232943
Complex I biogenesis,100,-0.0,0.0,0.0,0,0.5
Respiratory electron transport,100,-0.0,0.0,0.0,0,0.5
Formation of ATP by chemiosmotic coupling,100,-0.0,0.0,0.0,0,0.5
Glyoxylate metabolism and glycine degradation,950,0.1627093614634903,1.7852805563014973,0.0,0,0.7918189479535302
Pyruvate metabolism,150,0.19396214240446344,0.8704712212042087,0.0,0,0.6297602043458606
Pyruvate metabolism and Citric Acid TCA cycle,750,0.25314381213739,3.3149128554030023,0.0,0,0.7923410985653682
Citric acid cycle TCA cycle,750,0.25314381213739,2.498237973914705,0.0,0,0.7923410985653682
Histidine lysine phenylalanine tyrosine proline and tryptophan catabolism,1500,0.06297879021735711,0.3231713139014535,0.0,0,0.8073124158287749
Mitochondrial tRNA aminoacylation,1450,0.011964729488268783,0.01778044803974661,0.0,0,0.7944821383797225
tRNA Aminoacylation,1450,0.031487322306724116,0.058040938784288884,0.0,0,0.7984554688565138
Cytosolic tRNA aminoacylation,950,0.02451821953772302,0.14993586408465426,0.0,0,0.7609675574651846
tRNA modification in the nucleus and cytosol,1150,0.01023831471425336,0.02897764975863331,0.0,0,0.7745896771540184
Branched_chain amino acid catabolism,1450,0.041204960094945106,0.10480415229660309,0.0,0,0.8004045201831624
Phase 4 _ resting membrane potential,800,0.0675301427132985,0.7134287413215527,0.0,0,0.7558528567073262
Mitochondrial translation initiation,800,0.08452550058469654,0.7050292796251072,0.0,0,0.7599671636894447
Mitochondrial translation termination,800,0.08452550058469654,0.40681872961994936,0.0,0,0.7599671636894447
Mitochondrial translation,800,0.0675301427132985,0.4533542606105402,0.0,0,0.7558528567073262
Mitochondrial translation elongation,800,0.0970227383074923,0.4626057612283154,0.0,0,0.7629482446683584
